Light Mode
$88.74 ↑ +0.00 (+0.00%) Trading Up from the previous close of $88.74, $0.87 below the day’s high of $89.61
+19.42 (+28.15%) / 6M
Momentum, market sentiment, and recent alerts
HSIC reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +21.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
| Ticker | Company | Price | Change |
|---|---|---|---|
| FSNUY | Fresenius SE & Co. KGaA Sponsored ADR | $14.86 | +2.34% |
| SRTOY | Sartorius Stedim Biotech SA Unsponsored ADR | $25.67 | +1.06% |
| FSPKF | Fisher & Paykel Healthcare Corporation Limited | $26.99 | -0.07% |
| EKTAF | Elekta AB Class B | $6.12 | +2.00% |
| EKTAY | Elekta AB Unsponsored ADR Class B | $6.02 | -2.27% |
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.